In This Study, Doctors Want To Evaluate The Safety And Effectiveness Of An Investigational Drug In Patients With Attenuated Psychosis Syndrome.
Posted Date: Jan 28, 2020
- Investigator: Caleb Adler
- Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
- Type of Study: Drug
A phase II randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period as an early intervention in patients with attenuated psychosis syndrome.
Age =16 And = 30 Years, Diagnostic Criteria For Attenuated Psychosis Syndrome
Psychotic, Young Adults, Adolescent
For More Information:
Raechel Cooley, B.A.